4 March 2020 - Drug companies fail to take account of the public interest and relentlessly focus on short term returns, say Mariana Mazzucato and Henry Lishi Li. 

But Ara Darzi argues that the profits drug companies make are vital for developing new medicines.

Read BMJ article